This site complies with the HONcode standard for trustworthy health information:
verify here.

Rewarding for
you and us
Defeat Diabetes Foundation

Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300
Madeira Beach, FL 33708

Drugs » Actos

Search our News Articles Archives for diabetes and health news. Search by word or phrase. The latest article will appear first.

Is Pioglitazone the Answer in Pre-diabetes?

Posted: Tuesday, April 05, 2011

A pill taken once a day in the morning prevented Type 2 diabetes in more than 70 percent of individuals whose obesity, ethnicity and other markers put them at highest risk for the disease.

EASD: Pioglitazone-Sitagliptin Combination Achieves Durable Glycemic Control

Posted: Sunday, October 03, 2010

Adding 50 mg of sitagliptin (Januvia) to pioglitazone (Actos) allowed patients with Type 2 diabetes to achieve sustained glycemic control, a yearlong trial showed.

More Evidence Actos and Avandia Increases Risk of Bone Fracture

Posted: Monday, August 09, 2010

The popular diabetes drugs Actos and Avandia boost the risk of fracture in older women, according to findings from a new study that echo those of earlier research.

TZD Patients Are 50% More Likely to Develop Bone Fractures

Posted: Sunday, March 07, 2010

A Henry Ford Hospital study finds women with Type 2 diabetes who take a commonly prescribed class of medications called TZD's to treat insulin resistance may be at a higher risk for developing bone fractures within 1 year of taking the medication.

Early Triple Therapy for Type 2 Diabetes

Posted: Wednesday, September 23, 2009

When metformin and a sulfonylurea or a glinide fail to bring Type 2 diabetes under control, adding pioglitazone may do the trick, French research suggests.

Diabetes Drug Improves Psoriasis

Posted: Wednesday, June 10, 2009

The diabetes drug pioglitazone (Actos) significantly improved psoriasis control when added to oral acitretin (Soriatane), data from a small clinical trial demonstrated. This could be an important finding due to the fact that many people with diabetes also have psoriasis.

Stopping Avandia Increases Blood Sugar Levels

Posted: Wednesday, April 29, 2009

Study found diabetics who discontinued use of the drug showed a worsening of control and management of their diabetes.

Liraglutide Has Low CVD Risk but May Be Blocked for Approval

Posted: Wednesday, April 15, 2009

Tumor data may block approval for diabetes drug liraglutide. An FDA advisory panel declined to recommend approval for the investigational diabetes drug liraglutide (Victoza), in light of animal studies linking the injection to thyroid cancer.

Rosiglitazone More Dangerous Than Pioglitazone for Elderly Diabetics

Posted: Monday, November 24, 2008

Two oral medications for type 2 diabetes, rosiglitazone and pioglitazone, have both been shown to have benefit and potentially high risk. A recent study has concluded that rosigilitazone is significantly more dangerous for older diabetics.

Combo of Diabetes Drugs Increases Mortality

Posted: Thursday, August 21, 2008

Combination treatment for type 2 diabetes using two classes of drugs -- metformin and sulfonylureas -- may increase the risk of hospitalization for cardiovascular disease and mortality, according to a new report.